The DOI matches its Crossref record.
When the Creation of a Consortium Provides Useful Answers: Experience of The Latin American DILI Network (LATINDILIN)
Abstract
Watch a video presentation of this article Watch the interview with the author (English) Watch the interview with the author (Spanish)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Results of ongoing DILI registry studies demonstrate that the spectrum of suspect drugs and demographics of afflicted patients substantially differ among countries and regions.17–24”
From AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury (2023) · cites this paper as [18]
In the citing paper
“For example, antimicrobials, central nervous system agents, immunomodulatory agents, and antineoplastic agents are more frequently implicated than antihypertensives.17–24”
From AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury (2023) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 17
- 2017, Drug‐induced liver injury: recent advances in diagnosis and risk assessment, Gut, 66, 1154, 10.1136/gutjnl-2016-313369 · DOI · Paper page
- 2011, Causality assessment methods in drug induced liver injury: strengths and weaknesses, J Hepatol, 55, 683, 10.1016/j.jhep.2011.02.007 · DOI · Paper page
- 2012, Building a Spanish Latin American network on drug induced liver injury: Much to get from a joint collaborative initiative, Ann Hepatol, 11, 544, 10.1016/S1665-2681(19)31469-3 · DOI
- 2016, Creating an effective clinical registry for rare diseases, United European Gastroenterol J, 4, 333, 10.1177/2050640615618042 · DOI
- 2014, Profile of idiosyncratic drug induced liver injury in Latin America. An analysis of published reports, Ann Hepatol, 13, 231, 10.1016/S1665-2681(19)30886-5 · DOI
- 2005, Drug‐induced liver injury: An analysis of 461 incidences submitted to the Spanish registry over a 10 year period, Gastroenterology, 129, 512, 10.1016/j.gastro.2005.05.006 · DOI · Paper page
- 2011, Hepatotoxicidad, un problema global con especificidades locales: Hacia la creación de una Red Hispano Latinoamericana de Hepatotoxicidad, Gastroenterol Hepatol, 34, 361, 10.1016/j.gastrohep.2011.01.003 · DOI
- 2016, The Latin American DILI Registry experience: A successful ongoing collaborative strategic initiative, Int J Mol Sci, 17, 313, 10.3390/ijms17030313 · DOI
- 2015, Features and outcomes of 899 patients with drug‐induced liver injury: The DILIN Prospective Study, Gastroenterology, 148, 1340, 10.1053/j.gastro.2015.03.006 · DOI · Paper page
- 2010, Single‐center experience with drug‐induced liver injury from India: causes, outcome, prognosis, and predictors of mortality, Am J Gastroenterol, 105, 2396, 10.1038/ajg.2010.287 · DOI · Paper page
- 2016, Cyproterone acetate induces a wide spectrum of acute liver damage including corticosteroid‐responsive hepatitis: report of 22 cases, Liver Int, 36, 302, 10.1111/liv.12899 · DOI
- 2016, Hepatotoxicity induced by coxibs: How concerned should we be?, Expert Opin Drug Saf, 15, 1463, 10.1080/14740338.2016.1225719 · doi:10.1080/14740338.2016.1225719
- 2018, Nitrofurantoin‐induced autoimmune liver disease: An analysis from the Latin American and Spanish DILI Registries, Ann Hepatol, 17, 1189 A
- 2015, Distinct phenotype of hepatotoxicity associated with illicit use of anabolic androgenic steroids, Aliment Pharmacol Ther, 41, 116, 10.1111/apt.13023 · DOI · Paper page
- 2014, Use of Hy’s law and a new composite algorithm to predict acute liver failure in patients with drug‐induced liver injury, Gastroenterology, 147, 109, 10.1053/j.gastro.2014.03.050 · DOI · Paper page
- 2018, High prevalence of ibuprofen drug‐induced liver injury in Spanish and Latin‐American Registries, Clin Gastroenterol Hepatol, 16, 292, 10.1016/j.cgh.2017.07.037 · DOI
- 2017, Association of liver injury from specific drugs, or groups of drugs, with polymorphisms in HLA and other genes in a genome‐wide association study, Gastroenterology, 152, 1078, 10.1053/j.gastro.2016.12.016 · DOI · Paper page
Cited by
Andrade, R. J., Chalasani, N., Björnsson, E. S., Suzuki, A., Kullak-Ublick, G. A., Watkins, P. B., Devarbhavi, H., Merz, M., Lucena, M. I., Kaplowitz, N., et al. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0105-0 · Cited by 924
Self-citationAASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury
Fontana, R. J., Liou, I., Reuben, A., Suzuki, A., Fiel, M. I., Lee, W., & Navarro, V. (2023) · Hepatology · doi:10.1002/hep.32689 · Cited by 340
Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry
Stephens, C., Robles-Diaz, M., Medina-Caliz, I., Garcia-Cortes, M., Ortega-Alonso, A., Sanabria-Cabrera, J., Gonzalez-Jimenez, A., Alvarez-Alvarez, I., Slim, M., Jimenez-Perez, M., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.01.029 · Cited by 148
Self-citationRoussel uclaf causality assessment method for drug-induced liver injury: Present and future
Danan, G., & Teschke, R. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00853 · Cited by 111
Teschke, R. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00730 · Cited by 62
Metadata
- Authors
- Bessone, F., Hernandez, N., Mendizabal, M., Sanchez, A., Paraná, R., Arrese, M., Tagle, M., Girala, M., Lizarzabal, M., Carrera, E., Brahm, J., Contreras, F., Mendez‐Sanchez, N., Santos, G., Nunes, V., Medina‐Caliz, I., Parra‐Martinez, C., Sanz‐Villanueva, L., Isabel Lucena, M., & Andrade, R. J.
- Affiliations
- Hospital Provincial del Centenario, University of Rosario School of Medicine,Rosario,Argentina
- Hospital de Clínicas,Montevideo,Uruguay
- Hospital Universitario Austral,Pilar, Buenos Aires,Argentina
- Hospital Universitario Prof. Edgard Santos,Salvador de Bahia,Brazil
- Universidad Católica Pontificia de Chile,Santiago,Chile
- Clínica Angloamericana,Lima,Perú
- Hospital de Clínicas,Asunción del Paraguay,Paraguay
- Hospital Universitario de Maracaibo,Maracaibo,Venezuela
- Hospital de Especialidades Eugenio Espejo,Quito,Ecuador
- Universidad Nacional Pedro Henriquez,Santo Domingo,República Dominicana
- Fundación Clínica Médica Sur,Mexico City,Mexico
- Unidad de Gestión Clínica de Ap Digestivo y Servicio de Farmacología Clínica, Instituto de Investigación Biomédica de Málaga,Hospital Universitario Virgen de la Victoria, Universidad de Málaga,Málaga,Spain
- Venue
- Clinical Liver Disease
- Published
- 2019-02
- Volume
- 13
- Issue
- 2
- Pages
- 51-57
- ISSN
- 2046-2484
- Cited by
- 33
- References
- 0
- Language
- en
- Licence
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: When the Creation of a Consortium Provides Useful Answers: Experience of The Latin American DILI Network (LATINDILIN). https://app.cochat.ai/papers/10.1002/cld.778
- The paper
- Bessone, F., Hernandez, N., Mendizabal, M., Sanchez, A., Paraná, R., Arrese, M., Tagle, M., Girala, M., Lizarzabal, M., Carrera, E., Brahm, J., Contreras, F., Mendez‐Sanchez, N., Santos, G., Nunes, V., Medina‐Caliz, I., Parra‐Martinez, C., Sanz‐Villanueva, L., Isabel Lucena, M., & Andrade, R. J. (2019). When the Creation of a Consortium Provides Useful Answers: Experience of The Latin American DILI Network (LATINDILIN). Clinical Liver Disease. https://doi.org/10.1002/cld.778
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.